MENU×

The Reality of MS and Walking

Talking about walking difficulty is a dialogue worth having. This one-on-one video series features real patients and healthcare professionals discussing their experiences with MS and walking.

Watch the videos below and let the conversations begin.

AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg, is the only product indicated to improve walking in patients with MS. This was demonstrated by an increase in walking speed.

AMPYRA does not work for everyone, and people experience different levels of response to the medication. Ask your doctor if AMPYRA may be right for you.

Video title:

Signs and symptoms of walking changes

The people in this video series are real people living with MS and real healthcare professionals who treat people with MS. All participants have been compensated for their time by Acorda Therapeutics®, Inc.

AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg, is the only product indicated to improve walking in patients with MS. This was demonstrated by an increase in walking speed.

Joy Bryant: MS Patient

View entire video

Watch the full interview as a real family living with MS discusses a range of topics related to walking and MS.

Dr. Thrower: Physician Expert

View entire video

Watch the full interview as Dr. Thrower, a neurologist, discusses a range of topics related to walking and MS.

Tracy Walker: Nurse Practitioner Expert

View entire video

Watch the full interview as Tracy Walker, a nurse practitioner, discusses a range of topics related to walking and MS.

Get the download on MS, walking, and AMPYRA.

Indication

AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg, is the only prescription medicine indicated to help improve walking in adults with MS. This was demonstrated by an increase in walking speed.

Important Safety Information

Do not take AMPYRA if you have ever had a seizure, have certain types of kidney problems, or are allergic to dalfampridine (4-aminopyridine), the active ingredient in AMPYRA.

Indication & Important Safety Information

AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg, is the only prescription medicine indicated to help improve walking in adults with MS. This was demonstrated by an increase in walking speed.

IMPORTANT SAFETY INFORMATION

Do not take AMPYRA if you

  • have ever had a seizure,
  • have certain types of kidney problems, or
  • are allergic to dalfampridine (4-aminopyridine), the active ingredient in AMPYRA.

Take AMPYRA exactly as prescribed by your doctor.

Before taking AMPYRA, tell your doctor if you

  • have kidney problems or any other medical conditions
  • are taking compounded 4-aminopyridine
  • are pregnant or plan to become pregnant. It is not known if AMPYRA will harm your unborn baby.
  • are breast-feeding or plan to breast-feed. It is not known if AMPYRA passes into your breast milk. You and your doctor should decide if you will take AMPYRA or breast-feed. You should not do both.
  • are taking any other medicines

Stop taking AMPYRA and call your doctor right away if you have a seizure while taking AMPYRA. You could have a seizure even if you never had a seizure before. Your chance of having a seizure is higher if you take too much AMPYRA or if your kidneys have a mild decrease of function, which is common after age 50. Your doctor may do a blood test to check how well your kidneys are working before you start AMPYRA.

AMPYRA should not be taken with other forms of 4-aminopyridine (4-AP, fampridine), since the active ingredient is the same.

AMPYRA may cause serious side effects, including

  • severe allergic reactions. Stop taking AMPYRA and call your doctor right away or get emergency medical help if you have shortness of breath or trouble breathing, swelling of your throat or tongue, or hives;
  • kidney or bladder infections.

The most common adverse events for AMPYRA in MS patients were urinary tract infection, trouble sleeping, dizziness, headache, nausea, weakness, back pain, problems with balance, multiple sclerosis relapse, burning, tingling, or itching of your skin, irritation in your nose and throat, constipation, indigestion, and pain in your throat.

Please see Patient Medication Guide for additional safety information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.